Hong Wang
Impact in
- Oncology top 0.2%
- Cutaneous Melanoma Detection and Management
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Research top 0.2%
- MicroRNA in disease regulation
Papers in
- Cancer Research 106
- MicroRNA in disease regulation 28
- Oncology 179
- Cancer Immunotherapy and Biomarkers 38
- Cancer Cells and Metastasis 24
- Co-authors
- Robert M. ElashoffDonald L. MortonScott M. EisenkopRichard L. FriedmanSamir HanashDave S.�B. HoonJoel S. GreenbergerMichael W. Epperly
- Journals
- Journal of Clinical Oncology (25 papers)Radiation Research (19 papers)Cancer Research (14 papers)Blood (13 papers)PLoS ONE (11 papers)
- Partner nations
- United StatesChinaAustralia
In The Last Decade
Hong Wang
710 papers receiving 24.7k citations
Hit Papers
Peers
Comparison fields: 5 of 192
- Oncology 6.9k
- Cancer Research 3.1k
- Immunology 4.1k
- Molecular Biology 9.9k
- Pathology and Forensic Medicine 2.0k
Countries citing papers authored by Hong Wang
This map shows the geographic impact of Hong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Wang more than expected).
Fields of papers citing papers by Hong Wang
This network shows the impact of papers produced by Hong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Wang. The network helps show where Hong Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Hong Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 10 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 1 | |
| 7 | 2022 | 12 | |
| 8 | Evaluation of the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer | 2020 | 7 |
| 9 | Major Hepatectomy in Elderly Patients with Large Hepatocellular Carcinoma: A Multicenter Retrospective Observational Study | 2020 | 1 |
| 10 | 2019 | 15 | |
| 11 | 2017 | 85 | |
| 12 | 2017 | 58 | |
| 13 | 2015 | 26 | |
| 14 | 2013 | 175 | |
| 15 | 2013 | 68 | |
| 16 | 2012 | 79 | |
| 17 | 2011 | 26 | |
| 18 | 2008 | 117 | |
| 19 | 2005 | 25 | |
| 20 | 1999 | 436 |
About Hong Wang
Hong Wang is a scholar working on Cancer Research, Oncology, Hematology, Immunology and Genetics, having authored 749 papers that have together received 25.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (38 papers), Immunotherapy and Immune Responses (31 papers), Effects of Radiation Exposure (29 papers), MicroRNA in disease regulation (28 papers), Hematopoietic Stem Cell Transplantation (26 papers), Mesenchymal stem cell research (25 papers), Cancer Cells and Metastasis (24 papers) and Immune Cell Function and Interaction (23 papers). The work is most often cited by research in Oncology (6.9k citations), Cancer Research (3.1k citations), Immunology (4.1k citations), Molecular Biology (9.9k citations) and Pathology and Forensic Medicine (2.0k citations). Hong Wang has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Robert M. Elashoff, Donald L. Morton, Scott M. Eisenkop, Richard L. Friedman, Samir Hanash, Dave S.�B. Hoon, Joel S. Greenberger, Michael W. Epperly, Richard Essner and John M. Kirkwood. Their work appears in journals such as Journal of Clinical Oncology, Radiation Research, Cancer Research, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.